Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Methylphenidate-Containing Medicines-Availability of web-based educational tools
Notice type:
3rd Party Publications
Date:
01/05/2013
Product name or type:
Methylphenidate-Containing Medicines-Availability of web-based educational tools
Reference:
MIMS Publication - May 2013
Background Information Or Related Documents:
Methylphenidate-Containing Medicines-Availability of web-based educational tools Document
Further Information:
Methylphenidate-Containing Medicines-Availability of web-based educational tools - MIMS Publication May 2013
Lenalidomide (Revlimid)-Risk of Serious Hepatic Adverse Reactions. Routine monitoring of liver function now recommended - MIMS Oncology Supplement May 2013
« Back
Date Printed: 14/05/2024